0.3391  0.002 (0.5%)		07-26 16:00
Open: 0.339 High: 0.3394 Volume: 628,243		Pre. Close: 0.3374 Low: 0.3371 Market Cap: 92(M)

Short term
Mid term
Targets	6-month :	0.39	1-year :	0.46
Resists	First :	0.34	Second :	0.39
Pivot price	0.33
Supports	First :	0.32	Second :	0.31
MAs	MA(5) :	0.33	MA(20) :	0.33
	MA(100) :	0.28	MA(250) :	0.28
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	81.9	D(3) :	83.8
RSI	RSI(14): 61.8
52-week	High :	0.4	Low :	0.2

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ ASXC ] has closed below upper band by 47.3%. Bollinger Bands are 84.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.34 - 0.34	0.34 - 0.34
Low:	0.33 - 0.33	0.33 - 0.34
Close:	0.34 - 0.34	0.34 - 0.34

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.

Wed, 24 Jul 2024
Asensus Surgical Announces The Rocky Mountain Hospital for - GlobeNewswire

Wed, 24 Jul 2024
Asensus Surgical Announces The Rocky Mountain Hospital for Children in Denver, Colorado to Initiate Senhance Surgery Program - StockTitan

Tue, 23 Jul 2024
Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in Urology - Markets Insider

Tue, 23 Jul 2024
Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in Urology - StockTitan

Tue, 16 Jul 2024
Asensus Surgical Announces LKH-Universitätsklinikum Graz Hospital in Austria to Initiate Senhance Surgery Program - StockTitan

Fri, 07 Jun 2024
SHAREHOLDER ALERT: The M&A Class Action Investigates the Merger of Asensus Surgical, Inc. - ASXC - PR Newswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: AMEX
Sector: Healthcare
Industry: Medical - Devices
Shares Out	0 (M)
Shares Float	264 (M)
Held by Insiders	2.597e+008 (%)
Held by Institutions	1.7 (%)
Shares Short	18,600 (K)
Shares Short P.Month	0 (K)

EPS	-7.613e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-1 %
Return on Assets (ttm)	826.7 %
Return on Equity (ttm)	-50.1 %
Qtrly Rev. Growth	5.61e+006 %
Gross Profit (p.s.)	-37.83
Sales Per Share	-64.95
EBITDA (p.s.)	-2.49342e+006
Qtrly Earnings Growth	-0.4 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-64 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	-0.01
Price to Cash Flow	2.86

Dividend	0
Forward Dividend	2.013e+007
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.